These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

803 related items for PubMed ID: 28669339

  • 1. DNA Fragmentation, Cell Cycle Arrest, and Docking Study of Novel Bis Spiro-cyclic 2-oxindole of Pyrimido[4,5-b]quinoline-4,6-dione Derivatives Against Breast Carcinoma.
    Mohamed MF, Abdelmoniem AM, Elwahy AHM, Abdelhamid IA.
    Curr Cancer Drug Targets; 2018; 18(4):372-381. PubMed ID: 28669339
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
    Tantawy MA, Sroor FM, Mohamed MF, El-Naggar ME, Saleh FM, Hassaneen HM, Abdelhamid IA.
    Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
    Saxena R, Gupta G, Manohar M, Debnath U, Popli P, Prabhakar YS, Konwar R, Kumar S, Kumar A, Dwivedi A.
    Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
    [Abstract] [Full Text] [Related]

  • 7. Synthesis, Biological Evaluation and In Silico Studies of Certain Oxindole-Indole Conjugates as Anticancer CDK Inhibitors.
    Al-Warhi T, El Kerdawy AM, Aljaeed N, Ismael OE, Ayyad RR, Eldehna WM, Abdel-Aziz HA, Al-Ansary GH.
    Molecules; 2020 Apr 27; 25(9):. PubMed ID: 32349307
    [Abstract] [Full Text] [Related]

  • 8. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines.
    Kilic-Kurt Z, Bakar-Ates F, Karakas B, Kütük Ö.
    Anticancer Agents Med Chem; 2018 Apr 27; 18(9):1303-1312. PubMed ID: 29866023
    [Abstract] [Full Text] [Related]

  • 9. New cell cycle checkpoint pathways regulators with 2-Oxo-indoline scaffold as potential anticancer agents: Design, synthesis, biological activities and in silico studies.
    Abd El-Wahab HAA, Mansour HS, Ali AM, El-Awady R, Aboul-Fadl T.
    Bioorg Chem; 2022 Mar 27; 120():105622. PubMed ID: 35091290
    [Abstract] [Full Text] [Related]

  • 10. Molecular docking studies, biological evaluation and synthesis of novel 3-mercapto-1,2,4-triazole derivatives.
    Ghanaat J, Khalilzadeh MA, Zareyee D.
    Mol Divers; 2021 Feb 27; 25(1):223-232. PubMed ID: 32067134
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones.
    Mohamed MF, Hassaneen HM, Abdelhamid IA.
    Eur J Med Chem; 2018 Jan 01; 143():532-541. PubMed ID: 29207336
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis, bioactivity assessment, molecular docking and ADMET studies of new chromone congeners exhibiting potent anticancer activity.
    Abo-Salem HM, El Souda SSM, Shafey HI, Zoheir KMA, Ahmed KM, Mahmoud K, Mahrous KF, Fawzy NM.
    Sci Rep; 2024 Apr 26; 14(1):9636. PubMed ID: 38671055
    [Abstract] [Full Text] [Related]

  • 15. Design and synthesis of novel pyrazolo[3,4-d]pyrimidin-4-one bearing quinoline scaffold as potent dual PDE5 inhibitors and apoptotic inducers for cancer therapy.
    Ibrahim TS, Hawwas MM, Taher ES, Alhakamy NA, Alfaleh MA, Elagawany M, Elgendy B, Zayed GM, Mohamed MFA, Abdel-Samii ZK, Elshaier YAMM.
    Bioorg Chem; 2020 Dec 26; 105():104352. PubMed ID: 33080494
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hybridized Quinoline Derivatives as Anticancer Agents: Design, Synthesis, Biological Evaluation and Molecular Docking.
    Selim MR, Zahran MA, Belal A, Abusaif MS, Shedid SA, Mehany ABM, Elhagali GAM, Ammar YA.
    Anticancer Agents Med Chem; 2019 Dec 26; 19(4):439-452. PubMed ID: 30417798
    [Abstract] [Full Text] [Related]

  • 18. Spiro-oxindoles as a Promising Class of Small Molecule Inhibitors of p53-MDM2 Interaction Useful in Targeted Cancer Therapy.
    Gupta AK, Bharadwaj M, Kumar A, Mehrotra R.
    Top Curr Chem (Cham); 2017 Feb 26; 375(1):3. PubMed ID: 27943171
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and SARs study of novel spiro-oxindoles as potent antiproliferative agents with CDK-2 inhibitory activities.
    Al-Jassas RM, Islam MS, Al-Majid AM, Nafie MS, Haukka M, Rahman AFMM, Alayyaf AMA, Barakat A.
    Arch Pharm (Weinheim); 2023 Aug 26; 356(8):e2300185. PubMed ID: 37253118
    [Abstract] [Full Text] [Related]

  • 20. IND-2, a pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells.
    Karthikeyan C, Lee C, Moore J, Mittal R, Suswam EA, Abbott KL, Pondugula SR, Manne U, Narayanan NK, Trivedi P, Tiwari AK.
    Bioorg Med Chem; 2015 Feb 01; 23(3):602-11. PubMed ID: 25537531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.